Immunoglobulins and uses thereof
US12134636B2 · kind B2 · utility
0Cited by
15References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2020 |
| Grant date | Nov 5, 2024 |
| Priority date | — |
| Expiry date | Jun 22, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a monoclonal antibody platform designed to be coupled to therapeutic peptides to increase the half-life of the therapeutic peptide in a subject. The invention also relates to pharmaceutical compositions and methods for use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.